EP3143990
Samsetningar sem innihalda 2-amínó-2-[2-(4-oktýlfenýl)etýl]própan-1,3-díól
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2012EP published:
27.11.2019EP application number:
16176665.4
EP translation filed:
17.2.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
29.3.2032Expiry date:
29.3.2027Next due date:
31.3.2027
Title:
FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL
Timeline
Today
30.3.2012EP application
27.11.2019EP Publication
17.2.2020Translation submitted
15.3.2020Registration published
29.3.2027Expires
Owner
Name:
NOVARTIS AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
RANE, SupriyaAddress:
East Hanover, New Jersey, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161470747 PDate:
1.4.2011Country:
US
Number:
201161545835 PDate:
11.10.2011Country:
US
Classification
Categories:
A61K 9/16, A61K 31/137, A61P 37/06, A61K 47/40, A61K 9/20, A61K 9/48, A61K 31/661
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 25.2.2020
Expires: 29.3.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.2.2021
Expires: 29.3.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 24.2.2022
Expires: 29.3.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.2.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.2.2024
Expires: 29.3.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 4.3.2025
Expires: 29.3.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.3.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.